Replies to post #208244 on Biotech Values

[DewDiligence]

Addendum: BMY stands to benefit more than most Big Pharma from a reduction in the US corporate tax rate.

On Twitter, people are trying to build a DCF model to calculate the NPV of what BMY will receive from MRK in the PD-1 patent settlement announced today, but they don't know what tax rate to apply to this income.